The move follows a dramatic breakup in June between Hims & Hers and Danish drug maker Novo Nordisk, which makes the brand name weight loss drug Wegovy. Novo Nordisk accused the Hims & Hers of ...

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.

More doses of Novo Nordisk’s popular weight loss drug Wegovy are back in stock in the U.S. after years of shortages and just days after all doses of Eli Lilly’s rival injection Zepbound became ...

The new data shows that overall, for all the drugs included in the study, only about 15% were still on their medication after two years. For Wegovy, 24.1% of patients persisted with therapy over ...